Pacira BioSciences
PCRX
PCRX
261 hedge funds and large institutions have $1.46B invested in Pacira BioSciences in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 86 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more call options, than puts
Call options by funds: $6.41M | Put options by funds: $6.14M
0.09% less ownership
Funds ownership: 102.18% → 102.08% (-0.09%)
23% less capital invested
Capital invested by funds: $1.88B → $1.46B (-$427M)
Holders
261
Holding in Top 10
5
Calls
$6.41M
Puts
$6.14M
Top Buyers
| 1 | +$33.7M | |
| 2 | +$16.6M | |
| 3 | +$12M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$11.2M |
| 5 |
CC
Clearline Capital
New York
|
+$10.8M |
Top Sellers
| 1 | -$26.2M | |
| 2 | -$25.8M | |
| 3 | -$16.9M | |
| 4 |
Jennison Associates
New York
|
-$12.4M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$8.03M |